Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome (EFFORT2)
Primary Purpose
Acute Deep Vein Thrombosis
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Exercise
Control
Sponsored by
About this trial
This is an interventional treatment trial for Acute Deep Vein Thrombosis focused on measuring Deep vein thrombosis, Post thrombotic syndrome, Thrombus resolution
Eligibility Criteria
Inclusion Criteria:
- Acute Lower Extremity DVT
- Documented by ultrasound, CT/MR venogram, or conventional venogram
- Documented within 4 weeks of onset of symptoms
- Age 18 years
Exclusion Criteria:
- Peripheral arterial disease (disabling claudication, rest pain, tissue loss) with ABI<0.5
- Immediate need for thrombolysis/thrombectomy
- DVT involving the IVC
- Contraindication to anticoagulation
- Contraindications to exercise training
- Medical illness interfering with evaluation/follow-up
- Life expectancy <2 years
- Pregnancy
- Inability to walk
- Hemodynamically significant PE
Sites / Locations
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Control
Exercise
Arm Description
Standard care: anticoagulation, compression & ad-lib ambulation
Standard care + Interventional Exercise therapy
Outcomes
Primary Outcome Measures
Post Thrombotic Syndrome (Villalta Score)
Post Thrombotic Syndrome (Villalta Score)
Quality of LIfe (SF 36, VEINS-QOL)
Quality of LIfe (SF 36, VEINS-QOL)
Secondary Outcome Measures
Full Information
NCT ID
NCT02148029
First Posted
May 21, 2014
Last Updated
October 26, 2021
Sponsor
VA Office of Research and Development
Collaborators
University of Maryland, College Park
1. Study Identification
Unique Protocol Identification Number
NCT02148029
Brief Title
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
Acronym
EFFORT2
Official Title
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
July 1, 2014 (Actual)
Primary Completion Date
August 31, 2021 (Actual)
Study Completion Date
August 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
University of Maryland, College Park
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Despite standard care, 25%-50% of patients with clots in the deep veins of the arms and legs progress to chronic post-clot problems resulting in significant disability, loss of productivity, and healthcare costs. Reverse flow in the veins from an organizing clot is the primary cause of post-clot problems. Veins with early clot breakdown have a lower incidence of reverse flow. The investigators have observed that clot breakdown is enhanced by increased blood flow and that moderate arm and leg exercise result in increased venous blood flow. Hence, the investigators predict that a supervised exercise program in patients with deep vein clots could increase leg vein blood flow, accelerate clot breakdown, and decrease the risk of post clot problems. The primary hypothesis is that increased blood flow across the clot (induced by supervised exercise) will increase clot breakdown and decrease severity of post clot problems. The investigators are conducting a randomized clinical trial of standard therapy compared to progressive exercise training in patients with leg deep vein clots.
Detailed Description
Standard anticoagulation therapy for acute deep vein thrombosis (DVT) reflects the current short term focus on preventing pulmonary embolism (PE) and recurrent DVT. Despite standard care, 25% to 50% of patients with DVT progress to the chronic post-thrombotic syndrome (PTS) resulting in significant disability, loss of productivity, and healthcare costs. The investigators postulate that a supervised exercise program in patients with acute DVT could increase lower extremity venous flow, accelerate thrombus resolution, and thereby decrease the risk of PTS. If the patient is unable to perform exercises, NMES (neuromuscular electrical stimulation) will be used to induce contraction of the muscles of the lower extremities.
Aim 1 will test whether a 3-month exercise program has long-term clinical benefits in acute DVT. The primary outcome measures will be Villalta score for PTS and VEINS-QOL score (Venous Insufficiency Epidemiological and Economic Study-QOL) for venous quality of life at 2 years of follow-up. Aim 2 will evaluate whether exercise therapy in patients with acute DVT enhances thrombus resolution. Aim 3 will assess the relationship between PTS, venous hemodynamics and exercise capacity.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Deep Vein Thrombosis
Keywords
Deep vein thrombosis, Post thrombotic syndrome, Thrombus resolution
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
155 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
Active Comparator
Arm Description
Standard care: anticoagulation, compression & ad-lib ambulation
Arm Title
Exercise
Arm Type
Experimental
Arm Description
Standard care + Interventional Exercise therapy
Intervention Type
Other
Intervention Name(s)
Exercise
Intervention Description
Upper and Lower extremity exercise
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
Standard care: anticoagulation, compression & ad-lib ambulation
Primary Outcome Measure Information:
Title
Post Thrombotic Syndrome (Villalta Score)
Description
Post Thrombotic Syndrome (Villalta Score)
Time Frame
2 years
Title
Quality of LIfe (SF 36, VEINS-QOL)
Description
Quality of LIfe (SF 36, VEINS-QOL)
Time Frame
2 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Acute Lower Extremity DVT
Documented by ultrasound, CT/MR venogram, or conventional venogram
Documented within 4 weeks of onset of symptoms
Age 18 years
Exclusion Criteria:
Peripheral arterial disease (disabling claudication, rest pain, tissue loss) with ABI<0.5
Immediate need for thrombolysis/thrombectomy
DVT involving the IVC
Contraindication to anticoagulation
Contraindications to exercise training
Medical illness interfering with evaluation/follow-up
Life expectancy <2 years
Pregnancy
Inability to walk
Hemodynamically significant PE
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brajesh K Lal, MD
Organizational Affiliation
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Official's Role
Principal Investigator
Facility Information:
Facility Name
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
City
Baltimore
State/Province
Maryland
ZIP/Postal Code
21201
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome
We'll reach out to this number within 24 hrs